Two-stage breast cancer screening in the developing world

World Journal of Surgery

Volumn 35, Issue 3, 2011, Pages 698-699

  Batsis, Charalabos ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; BREAST TUMOR; CANCER STAGING; COMPARATIVE STUDY; DEVELOPING COUNTRY; EARLY DIAGNOSIS; ECHOMAMMOGRAPHY; EGYPT; FEMALE; HEALTH SERVICE; HUMAN; MAMMOGRAPHY; MASS SCREENING; METHODOLOGY; MIDDLE AGED; NOTE; PHYSICAL EXAMINATION; STATISTICS; TUMOR VOLUME;

ADULT; AGED; BREAST NEOPLASMS; DEVELOPING COUNTRIES; EARLY DETECTION OF CANCER; EGYPT; FEMALE; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; NEOPLASM STAGING; PHYSICAL EXAMINATION; TUMOR BURDEN; ULTRASONOGRAPHY, MAMMARY;

EID: 79952191869     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-010-0808-6     Document Type: Letter

References (15)

1. A Denewer O Hussein O Farouk, et al. 2010 Cost-effectiveness of clinical breast assessment-based screening in rural Egypt World J Surg 34 2204 2210 10.1007/s00268-010-0620-3 20533039
2. S Wacholder P Hartge R Prentice, et al. 2010 Performance of common genetic variants in breast-cancer risk models N Engl J Med 362 986 993 1:CAS:528:DC%2BC3cXjs1Kit7g%3D 10.1056/NEJMoa0907727 20237344
3. D Ziogas DH Roukos 2009 Genetics and personal genomics for personalized breast cancer surgery: progress and challenges in research and clinical practice Ann Surg Oncol 16 7 1771 1782 10.1245/s10434-009-0436-2 19322611
4. C Katsios DH Roukos 2010 Individual genomes and personalized medicine: life diversity and complexity Per Med 7 4 347 350 1:CAS:528:DC%2BC3cXosFCktrc%3D 10.2217/pme.10.30
5. DH Roukos D Ziogas 2010 From tumor size and HER2 status to systems oncology for very early breast cancer treatment Expert Rev Anticancer Ther 10 2 123 128 1:CAS:528:DC%2BC3cXhsFGitLw%3D 10.1586/era.09.177 20131987
6. DH Roukos 2010 Complete genome sequencing and network modeling to overcome trastuzumab resistance Pharmacogenomics 11 8 1039 1043 1:CAS:528:DC%2BC3cXhtVWmt7zE 10.2217/pgs.10.104 20704462
7. DH Roukos 2010 Next-generation, genome sequencing-based biomarkers: concerns and challenges for medical practice Biomark Med 4 4 583 586 10.2217/bmm.10.70 20701445
8. DH Roukos C Katsios T Liakakos 2010 Genotype-phenotype map and molecular networks: a promising solution in overcoming colorectal cancer resistance to targeted treatment Expert Rev Mol Diagn 10 5 541 545 1:CAS:528: DC%2BC3cXosl2htr4%3D 10.1586/erm.10.49 20629500
9. DH Roukos 2010 Bionetworks-based personalized medicine versus comparative-effectiveness research or harmonization of both in cancer management? Expert Rev Mol Diagn 10 3 247 250 10.1586/erm.10.10 20370580
10. DH Roukos 2010 Systems medicine: a real approach for future personalized oncology? Pharmacogenomics 11 3 283 287 10.2217/pgs.10.36 20235782
11. DH Roukos 2010 Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care Expert Rev Mol Diagn 10 1 33 48 1:CAS:528:DC%2BD1MXhsFKgtbjP 10.1586/erm.09.69 20014921
12. Roukos DH (2009) Isolated tumor cells in breast cancer. N Engl J Med 361:1994-1995; author reply 1995-6
13. DH Roukos A Tzakos G Zografos 2009 Current concerns and challenges towards tailored anti-angiogenic therapy in cancer Expert Rev Anticancer Ther 9 10 1413 1416 10.1586/era.09.116 19828000
14. DH Roukos D Ziogas 2009 Human genetic and structural genomic variation: would genome-wide association studies be the solution for cancer complexity like Alexander the Great for the "Gordian Knot"? Ann Surg Oncol 16 3 774 775 10.1245/s10434-008-0056-2 18612696
15. DH Roukos 2010 Targeting gastric cancer with trastuzumab: new clinical practice and innovative developments to overcome resistance Ann Surg Oncol 17 14 17 10.1245/s10434-009-0766-0 19841980